Hydroxybiphenylamide GroEL/ES Inhibitors Are Potent Antibacterials against Planktonic and Biofilm Forms of Staphylococcus aureus

Trent Kunkle, Sanofar Abdeen, Nilshad Salim, Anne Marie Ray, McKayla Stevens, Andrew J. Ambrose, José Victorino, Yangshin Park, Quyen Hoang, Eli Chapman, Steven Johnson

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We recently reported the identification of a GroEL/ES inhibitor (1, N-(4-(benzo[d]thiazol-2-ylthio)-3-chlorophenyl)-3,5-dibromo-2-hydroxybenzamide) that exhibited in vitro antibacterial effects against Staphylococcus aureus comparable to vancomycin, an antibiotic of last resort. To follow up, we have synthesized 43 compound 1 analogs to determine the most effective functional groups of the scaffold for inhibiting GroEL/ES and killing bacteria. Our results identified that the benzothiazole and hydroxyl groups are important for inhibiting GroEL/ES-mediated folding functions, with the hydroxyl essential for antibacterial effects. Several analogs exhibited >50-fold selectivity indices between antibacterial efficacy and cytotoxicity to human liver and kidney cells in cell culture. We found that MRSA was not able to easily generate acute resistance to lead inhibitors in a gain-of-resistance assay and that lead inhibitors were able to permeate through established S. aureus biofilms and maintain their bactericidal effects.

Original languageEnglish (US)
Pages (from-to)10651-10664
Number of pages14
JournalJournal of Medicinal Chemistry
Volume61
Issue number23
DOIs
StatePublished - Dec 13 2018

Fingerprint

Biofilms
Hydroxyl Radical
Staphylococcus aureus
Vancomycin
Methicillin-Resistant Staphylococcus aureus
Cell Culture Techniques
Anti-Bacterial Agents
Bacteria
Kidney
Liver
Lead
In Vitro Techniques
2-hydroxybenzamide
benzothiazole

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Hydroxybiphenylamide GroEL/ES Inhibitors Are Potent Antibacterials against Planktonic and Biofilm Forms of Staphylococcus aureus. / Kunkle, Trent; Abdeen, Sanofar; Salim, Nilshad; Ray, Anne Marie; Stevens, McKayla; Ambrose, Andrew J.; Victorino, José; Park, Yangshin; Hoang, Quyen; Chapman, Eli; Johnson, Steven.

In: Journal of Medicinal Chemistry, Vol. 61, No. 23, 13.12.2018, p. 10651-10664.

Research output: Contribution to journalArticle

Kunkle, Trent ; Abdeen, Sanofar ; Salim, Nilshad ; Ray, Anne Marie ; Stevens, McKayla ; Ambrose, Andrew J. ; Victorino, José ; Park, Yangshin ; Hoang, Quyen ; Chapman, Eli ; Johnson, Steven. / Hydroxybiphenylamide GroEL/ES Inhibitors Are Potent Antibacterials against Planktonic and Biofilm Forms of Staphylococcus aureus. In: Journal of Medicinal Chemistry. 2018 ; Vol. 61, No. 23. pp. 10651-10664.
@article{d1ef90a94402412ba08fb706605ddbf4,
title = "Hydroxybiphenylamide GroEL/ES Inhibitors Are Potent Antibacterials against Planktonic and Biofilm Forms of Staphylococcus aureus",
abstract = "We recently reported the identification of a GroEL/ES inhibitor (1, N-(4-(benzo[d]thiazol-2-ylthio)-3-chlorophenyl)-3,5-dibromo-2-hydroxybenzamide) that exhibited in vitro antibacterial effects against Staphylococcus aureus comparable to vancomycin, an antibiotic of last resort. To follow up, we have synthesized 43 compound 1 analogs to determine the most effective functional groups of the scaffold for inhibiting GroEL/ES and killing bacteria. Our results identified that the benzothiazole and hydroxyl groups are important for inhibiting GroEL/ES-mediated folding functions, with the hydroxyl essential for antibacterial effects. Several analogs exhibited >50-fold selectivity indices between antibacterial efficacy and cytotoxicity to human liver and kidney cells in cell culture. We found that MRSA was not able to easily generate acute resistance to lead inhibitors in a gain-of-resistance assay and that lead inhibitors were able to permeate through established S. aureus biofilms and maintain their bactericidal effects.",
author = "Trent Kunkle and Sanofar Abdeen and Nilshad Salim and Ray, {Anne Marie} and McKayla Stevens and Ambrose, {Andrew J.} and Jos{\'e} Victorino and Yangshin Park and Quyen Hoang and Eli Chapman and Steven Johnson",
year = "2018",
month = "12",
day = "13",
doi = "10.1021/acs.jmedchem.8b01293",
language = "English (US)",
volume = "61",
pages = "10651--10664",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "23",

}

TY - JOUR

T1 - Hydroxybiphenylamide GroEL/ES Inhibitors Are Potent Antibacterials against Planktonic and Biofilm Forms of Staphylococcus aureus

AU - Kunkle, Trent

AU - Abdeen, Sanofar

AU - Salim, Nilshad

AU - Ray, Anne Marie

AU - Stevens, McKayla

AU - Ambrose, Andrew J.

AU - Victorino, José

AU - Park, Yangshin

AU - Hoang, Quyen

AU - Chapman, Eli

AU - Johnson, Steven

PY - 2018/12/13

Y1 - 2018/12/13

N2 - We recently reported the identification of a GroEL/ES inhibitor (1, N-(4-(benzo[d]thiazol-2-ylthio)-3-chlorophenyl)-3,5-dibromo-2-hydroxybenzamide) that exhibited in vitro antibacterial effects against Staphylococcus aureus comparable to vancomycin, an antibiotic of last resort. To follow up, we have synthesized 43 compound 1 analogs to determine the most effective functional groups of the scaffold for inhibiting GroEL/ES and killing bacteria. Our results identified that the benzothiazole and hydroxyl groups are important for inhibiting GroEL/ES-mediated folding functions, with the hydroxyl essential for antibacterial effects. Several analogs exhibited >50-fold selectivity indices between antibacterial efficacy and cytotoxicity to human liver and kidney cells in cell culture. We found that MRSA was not able to easily generate acute resistance to lead inhibitors in a gain-of-resistance assay and that lead inhibitors were able to permeate through established S. aureus biofilms and maintain their bactericidal effects.

AB - We recently reported the identification of a GroEL/ES inhibitor (1, N-(4-(benzo[d]thiazol-2-ylthio)-3-chlorophenyl)-3,5-dibromo-2-hydroxybenzamide) that exhibited in vitro antibacterial effects against Staphylococcus aureus comparable to vancomycin, an antibiotic of last resort. To follow up, we have synthesized 43 compound 1 analogs to determine the most effective functional groups of the scaffold for inhibiting GroEL/ES and killing bacteria. Our results identified that the benzothiazole and hydroxyl groups are important for inhibiting GroEL/ES-mediated folding functions, with the hydroxyl essential for antibacterial effects. Several analogs exhibited >50-fold selectivity indices between antibacterial efficacy and cytotoxicity to human liver and kidney cells in cell culture. We found that MRSA was not able to easily generate acute resistance to lead inhibitors in a gain-of-resistance assay and that lead inhibitors were able to permeate through established S. aureus biofilms and maintain their bactericidal effects.

UR - http://www.scopus.com/inward/record.url?scp=85058537102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058537102&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.8b01293

DO - 10.1021/acs.jmedchem.8b01293

M3 - Article

C2 - 30392371

AN - SCOPUS:85058537102

VL - 61

SP - 10651

EP - 10664

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 23

ER -